Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-07-19 Sale | 2021-07-21 5:21 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 10,000 | $126.43 | $1,264,348 | 498,558 (Indirect) | View |
| 2021-06-29 Sale | 2021-06-30 6:41 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 47,536 | $149.49 | $7,106,341 | 1,581,188 (Indirect Direct) | View |
| 2021-06-28 Sale | 2021-06-30 6:38 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 30,375 | $152.48 | $4,631,583 | 158,831 (Indirect Direct) | View |
| 2021-06-28 Purchase | 2021-06-30 5:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner | 157,895 | $19 | $3,000,005 | 2,097,938 (Indirect) | View |
| 2021-06-11 Sale | 2021-06-15 4:41 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 10,000 | $126.61 | $1,266,118 | 1,575,335 (Indirect Direct) | View |
| 2021-03-22 Sale | 2021-03-24 6:00 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 30,374 | $132.37 | $4,020,667 | 1,585,335 (Indirect Direct) | View |
| 2021-02-19 Sale | 2021-02-23 4:40 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 171,003 | $149.11 | $25,497,840 | 1,628,724 (Indirect Direct) | View |
| 2020-12-16 Sale | 2020-12-18 7:12 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 15,000 | $148.95 | $2,234,266 | 3,040,462 (Indirect Direct) | View |
| 2020-12-10 Sale(A) | 2020-12-17 7:14 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 33,000 | $143.35 | $4,730,448 | 3,055,462 (Indirect Direct) | View |
| 2020-12-10 Sale | 2020-12-14 7:11 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 33,000 | $143.35 | $4,730,448 | 3,055,462 (Indirect Direct) | View |
| 2020-12-07 Sale | 2020-12-09 7:54 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 171,004 | $154.53 | $26,424,505 | 3,088,462 (Indirect Direct) | View |
| 2020-11-30 Sale | 2020-12-01 7:13 pm | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 10,393 | $33.15 | $344,513 | 2,138,983 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-09 Option Award | 2022-06-10 5:35 pm | N/A 2032-06-09 | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2021-06-28 Other | 2021-06-30 6:41 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 1,416,648 | $0 | 1,581,188 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 5:05 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner | 38,309,520 | $0 | 2,097,938 (Indirect) | View |
| 2021-02-24 Option Award | 2021-06-25 5:00 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner | 3,575,000 | $2 | 9,896,460 (Indirect) | View |
| 2021-03-11 Option Award | 2021-06-25 5:00 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner | 2,699,328 | $2.9637 | 9,896,460 (Indirect) | View |
| 2021-06-23 Option Award | 2021-06-25 5:00 pm | N/A 2031-06-22 | Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner | 47,132 | $0 | 9,896,460 (Direct) | View |
Ownership | 2021-06-23 8:47 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner | 0 | $0 | 8,739,158 (Indirect) | View |
| 2021-06-18 Option Award | 2021-06-22 6:12 pm | N/A 2031-06-17 | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 5:36 pm | N/A 2031-06-10 | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-03-01 Other | 2021-03-03 4:23 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 407,434 | $0 | 1,365,779 (Indirect) | View |
| 2021-02-19 Other | 2021-02-23 4:40 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 1,416,648 | $0 | 1,628,724 (Indirect) | View |
| 2020-12-14 Other | 2020-12-16 6:58 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 21,412 | $0 | 5,650,304 (Indirect) | View |
| 2020-11-27 Other | 2020-12-01 7:13 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 443,053 | $0 | 2,138,983 (Indirect) | View |